4baseCare partners with Innovate Life Sciences at Dubai Science Park to unlock genomics research for precision oncology
Bengaluru (Karnataka) [India], October 23: 4baseCare, an Illumina Accelerator Company, which offers cutting-edge precision oncology solutions using advanced genomics and digital health technology, is excited to announce a strategic partnership to nurture technology transfer with Innovate Life Sciences’ state-of-the-art genomics lab at Dubai Science Park
The agreement was confirmed at an event held on October 17, 2024, in the esteemed presence of Marwan Abdulaziz Janahi, Senior Vice President of Dubai Science Park, one of TECOM Group PJSC’s 10 vibrant business districts across Dubai, and Iqbal Khan, CEO of Fajr Capital, as Guests of Honour. Their presence underscored the importance of this endeavor, not just for 4baseCare, but for every individual and family touched by cancer in Asia and the Middle East. This step marks a critical moment in their journey to advance precision oncology in the Middle East, a region where cancer rates continue to rise, affecting countless lives.
4baseCare’s partnership with Innovate Life Sciences will provide cutting-edge genomic testing solutions, including comprehensive cancer gene panels, whole exome sequencing, and transcriptome analysis. These advanced tools will enable oncologists to delve deeper into the genetic makeup of tumors, offering personalized and more effective treatment options.